Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference154 articles.
1. Duncan, R., Dimitrijevic, S. & Evagorou, E. G. The role of polymer conjugates in the diagnosis and treatment of cancer. S. T. P. Pharma Sciences 6, 237–263 (1996).
2. Donaruma, L. G. Synthetic biologically active polymers. Progr. Polym. Sci. 4, 1–25 (1974).
3. Duncan, R. in Handbook of Anticancer Drug Development (eds Budman, D., Calvert, H. & Rowinsky, E.) (Lippincott Williams & Wilkins, Baltimore, in the press). A detailed overview describing the rationale for the design and current clinical status of polymer–anticancer-drug conjugates.
4. Harris, J. M. & Chess, R. B. Effect of pegylation on pharmaceuticals. Nature Rev. Drug Discov. 2, 214–221 (2003). An excellent review describing PEG–protein technology and the current clinical status of PEGylated protein pharmaceuticals. An important complementary review to the one presented here.
5. Veronese, F. M. & Harris, J. M. (eds). Special issue: Peptide and protein PEGylation. Adv. Drug Deliv. Systems 54, 453–609 (2002).
Cited by
3006 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献